Marketing-authorisation holder · United States
Kadmon Pharmaceuticals LLC
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| REZUROCK200mg base · Tablet | Belumosudil | United States | Marketed | 2021 |
| Infergen9mcg/0.3ml (30mcg/ml) · Injection | Interferon alfacon-1 | United States | Withdrawn | 1997 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 1 | 1 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.